SIADH Flashcards
Define SIADH
Syndrome of Inappropriate ADH
Plasma ADH/vasopressin is inappropriately high for the existing plasma osmolality. Characterised by hypotonic hyponatraemia, concentrated urine and a euvolaemic state in the absence of stimuli for secretion
Aetiology of SIADH
Malignancy: small cell lung carcinoma, pancreas, prostate, thymus
CNS: Stroke, SAH/SDH, meningoencephalitis, head injury, SLE
Chest disease: TB, pneumonia, abscess, aspergillosis,
Endocrine: hypothyroidism, Addison’s
Drugs: opioids, psychotropics, SSRIs
Other: acute intermittent porphyria, trauma, major abdominal or thoracic surgery, HIV
Symptoms of SIADH
Mild (125-135) - asymptomatic
Nausea and vomiting Altered mental status Headache Muscle cramp/weakness Irritability Confusion Drowsiness Seizure Coma
P[Na+]<120mM = generalised weakness, poor mental function P[Na+}<110mM = confusion leading to coma and ultimately death
Signs of SIADH on examination
Mild - no signs
Severe:
Hypo-reflexia
Extensor plantar reflexes
Investigations for SIADH
Urinalysis: raised osmolality, raised sodium
Serum osmolality: reduced
U+Es: reduced sodium, reduced urea
TFTs: normal (exclude hypothyroidism)
Short synacthen test: exclude adrenal insufficiency
Renal function: exclude renal failure
Proteins and lipid profile + glucose: exclude pseudo-hyponatraemia
Diagnostic trial with normal saline infusion: serum sodium level does NOT improve after normal saline infusion
CXR/CT CAP/MRI: identify the cause
Criteria for SIADH diagnosis
- Reduced ↓ plasma osmolality
- Reduced ↓ Na+
- Raised ↑ urine osmolality (>100mosmol/kg, Na+ >20mmol/L)
- Absence of hypovolaemia/hypotension, oedema, renal failure, adrenal insufficiency and hypothyroidism
Management for SIADH
- Address hyponatraemia -> fluid restriction
- If ineffective -> democlocyclin
- Treat underlying cause
- Vasopressin (V2) receptor antagonists e.g. tolavaptan in chronic hyponatraemia
Severe (Seizure, coma): slow IV hypertonic 3% saline + furosemide
Complications of SIADH
Convulsions
Coma
Death
Central pontine myelinolysis (quadriparesis, respiratory arrest, fits)
Prognosis of SIADH
Depends on underlying cause
High morbidity and mortality if Na <110
central pontine myelinolysis mortality 50%